|
IFNAR1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.141060E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.574330E-02 |
| Normal-vs-Stage2 |
2.518100E-03 |
| Normal-vs-Stage3 |
7.418900E-04 |
| Normal-vs-Stage4 |
6.20839999999623E-05 |
| Stage1-vs-Stage2 |
1.376440E-01 |
| Stage1-vs-Stage3 |
1.148170E-01 |
| Stage1-vs-Stage4 |
5.095300E-03 |
| Stage2-vs-Stage3 |
7.446000E-01 |
| Stage2-vs-Stage4 |
4.479600E-01 |
| Stage3-vs-Stage4 |
2.153600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.375800E-03 |
| Normal-vs-AfricanAmerican |
2.766000E-01 |
| Normal-vs-Asian |
5.142000E-02 |
| Caucasian-vs-AfricanAmerican |
3.407400E-01 |
| Caucasian-vs-Asian |
5.636400E-01 |
| AfricanAmerican-vs-Asian |
6.589600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.046600E-04 |
| Normal-vs-Female |
4.398100E-03 |
| Male-vs-Female |
1.614200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.510400E-02 |
| Normal-vs-Age(41-60Yrs) |
8.775300E-04 |
| Normal-vs-Age(61-80Yrs) |
2.042800E-04 |
| Normal-vs-Age(81-100Yrs) |
5.468300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.041210E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.826090E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.035000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.340400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.335400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.729200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.338400E-02 |
| Classical-VS-Follicular |
1.445070E-04 |
| Classical-VS-Other |
3.850100E-02 |
| Classical-VS-Normal |
3.365600E-02 |
| Tall-VS-Follicular |
3.040000E-01 |
| Tall-VS-Other |
1.257240E-01 |
| Tall-VS-Normal |
7.382900E-03 |
| Follicular-VS-Other |
4.170200E-01 |
| Follicular-VS-Normal |
1.70562999999291E-05 |
| Other-VS-Normal |
7.595000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.813900E-04 |
| Normal-vs-N1 |
1.219770E-04 |
| N0-vs-N1 |
1.247620E-01 |
|
|
